Literature DB >> 23889044

Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors.

Rekha Chandran1, Stuart K Gardiner, Stephen D Smith, Stephen E Spurgeon.   

Abstract

Entities:  

Keywords:  hairy cell leukaemia; ourcomes; prognostic factors; survival; therapy

Mesh：

Year:  2013        PMID： 23889044     DOI： 10.1111/bjh.12490

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

Review 1.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

2.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

3.  Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.

Authors:  Yi Wang; Tingyu Wang; Ying Yu; Qi Wang; Yuting Yan; Ru Li; Qi Sun; Wenjie Xiong; Rui Lyu; Zhen Yu; Wei Liu; Weiwei Sui; Wenyang Huang; Huijun Wang; Chengwen Li; Jun Wang; Dehui Zou; Gang An; Jianxiang Wang; Lugui Qiu; Shuhua Yi
Journal:  Ann Hematol       Date:  2022-04-18       Impact factor: 3.673

Review 4.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

Review 5.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 6.  Hairy cell leukemia - immunotargets and therapies.

Authors:  Faisal Basheer; David M Bloxham; Mike A Scott; George A Follows
Journal:  Immunotargets Ther       Date:  2014-06-24

7.  Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis.

Authors:  Narendranath Epperla; Melissa Pavilack; Temitope Olufade; Richa Bashyal; Jieni Li; Shaum M Kabadi; Huseyin Yuce; Leslie Andritsos
Journal:  Orphanet J Rare Dis       Date:  2020-02-13       Impact factor: 4.123

8.  Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Authors:  Rudolf Benz; Kornelius Arn; Martin Andres; Thomas Pabst; Michael Baumann; Urban Novak; Felicitas Hitz; Urs Hess; Reinhard Zenhaeusern; Yves Chalandon; Ulrich Mey; Sabine Blum; Daniel Rauch; Alix O'Meara Stern; Nathan Cantoni; Mario Bargetzi; Elena Bianchi-Papina; Davide Rossi; Jakob Passweg; Andreas Lohri; Simona Berardi; Qiyu Li; Anita Feller; Georg Stussi
Journal:  Blood Adv       Date:  2020-08-11

9.  Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.

Authors:  Edouard Cornet; Alain Delmer; Pierre Feugier; Francine Garnache-Ottou; David Ghez; Véronique Leblond; Vincent Levy; Frédéric Maloisel; Daniel Re; Jean-Marc Zini; Xavier Troussard
Journal:  Ann Hematol       Date:  2014-07-05       Impact factor: 3.673

Review 10.  Skin changes in hairy cell leukemia.

Authors:  Ewa Robak; Dorota Jesionek-Kupnicka; Tadeusz Robak
Journal:  Ann Hematol       Date:  2020-11-20       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.